ABIVAX Société Anonyme Statistics
Total Valuation
ABIVAX Société Anonyme has a market cap or net worth of EUR 723.76 million. The enterprise value is 537.23 million.
Market Cap | 723.76M |
Enterprise Value | 537.23M |
Important Dates
The next estimated earnings date is Monday, September 9, 2024.
Earnings Date | Sep 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ABIVAX Société Anonyme has 63.27 million shares outstanding. The number of shares has increased by 0.04% in one year.
Shares Outstanding | 63.27M |
Shares Change (YoY) | +0.04% |
Shares Change (QoQ) | -0.03% |
Owned by Insiders (%) | 3.62% |
Owned by Institutions (%) | 30.06% |
Float | 26.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 109.65 |
PB Ratio | 3.67 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.64 |
EV / Sales | 119.57 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.52 |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 37.99.
Current Ratio | 4.08 |
Quick Ratio | 4.00 |
Debt / Equity | 37.99 |
Debt / EBITDA | n/a |
Debt / FCF | -0.76 |
Interest Coverage | -9.22 |
Financial Efficiency
Return on equity (ROE) is -145.41% and return on invested capital (ROIC) is -48.74%.
Return on Equity (ROE) | -145.41% |
Return on Assets (ROA) | -39.57% |
Return on Capital (ROIC) | -48.74% |
Revenue Per Employee | 73,656 |
Profits Per Employee | -2.42M |
Employee Count | 61 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.72% in the last 52 weeks. The beta is 1.46, so ABIVAX Société Anonyme's price volatility has been higher than the market average.
Beta (5Y) | 1.46 |
52-Week Price Change | -33.72% |
50-Day Moving Average | 11.41 |
200-Day Moving Average | 11.86 |
Relative Strength Index (RSI) | 62.32 |
Average Volume (20 Days) | 24,822 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ABIVAX Société Anonyme had revenue of EUR 4.49 million and -147.74 million in losses. Loss per share was -3.43.
Revenue | 4.49M |
Gross Profit | 4.49M |
Operating Income | -127.46M |
Pretax Income | -147.74M |
Net Income | -147.74M |
EBITDA | -127.25M |
EBIT | -127.46M |
Loss Per Share | -3.43 |
Balance Sheet
The company has 260.99 million in cash and 74.47 million in debt, giving a net cash position of 186.53 million or 2.95 per share.
Cash & Cash Equivalents | 260.99M |
Total Debt | 74.47M |
Net Cash | 186.53M |
Net Cash Per Share | 2.95 |
Equity (Book Value) | 196.01M |
Book Value Per Share | 3.12 |
Working Capital | 215.93M |
Cash Flow
In the last 12 months, operating cash flow was -97.13 million and capital expenditures -265,000, giving a free cash flow of -97.40 million.
Operating Cash Flow | -97.13M |
Capital Expenditures | -265,000 |
Free Cash Flow | -97.40M |
FCF Per Share | -1.54 |
Margins
Gross Margin | 100.00% |
Operating Margin | -2,836.79% |
Pretax Margin | -3,288.23% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -2,167.71% |
Dividends & Yields
ABIVAX Société Anonyme does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.04% |
Shareholder Yield | -0.04% |
Earnings Yield | -29.99% |
FCF Yield | -13.46% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |